Filing Details

Accession Number:
0001209191-14-061668
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-03 16:13:30
Reporting Period:
2014-10-01
Filing Date:
2014-10-03
Accepted Time:
2014-10-03 16:13:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190290 Elaine Ullian C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-01 5,000 $34.32 10,265 No 4 M Direct
Common Stock Disposition 2014-10-01 808 $106.42 9,457 No 4 S Direct
Common Stock Disposition 2014-10-01 2,592 $107.48 6,865 No 4 S Direct
Common Stock Disposition 2014-10-01 1,100 $108.32 5,765 No 4 S Direct
Common Stock Disposition 2014-10-01 300 $109.30 5,465 No 4 S Direct
Common Stock Disposition 2014-10-01 100 $110.45 5,365 No 4 S Direct
Common Stock Disposition 2014-10-01 100 $111.57 5,265 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-10-01 5,000 $0.00 5,000 $34.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2016-05-31 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Ms. Ullian's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $106.42 (range $105.93 to $106.89).
  3. Ms. Ullian undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $107.48 (range $106.93 to $107.92).
  5. Open market sales reported on this line occurred at a weighted average price of $108.32 (range $107.99 to $108.81).
  6. Open market sales reported on this line occurred at a weighted average price of $109.30 (range $109.24 to $109.42).
  7. Fully vested.